Carregant...
Initial Testing (Stage 1) of the Anti-Microtubule Agents Cabazitaxel and Docetaxel, by the Pediatric Preclinical Testing Program
BACKGROUND: While microtubule destabilizing agents (principally vincristine) are in common use in pediatric oncology, the microtubule stabilizing taxanes are uncommonly used to treat childhood cancers. Cabazitaxel has been reported to have activity superior to that of docetaxel in preclinical models...
Guardat en:
| Publicat a: | Pediatr Blood Cancer |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758191/ https://ncbi.nlm.nih.gov/pubmed/26154614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25611 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|